DCP
RMD icon

Distillate Capital Partners’s ResMed RMD Stock Holding History

Distillate Capital Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.1M Buy
67,349
+624
+0.9% +$156K 0.8% 65
2025
Q4 		$16.1M Buy
+66,725
New +$17.1M 0.83% 54

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Distillate Capital Partners's RMD Position: Q1 2026 in Review

Distillate Capital Partners increased its ResMed (RMD) stake by 0.94% in Q1 2026, buying an estimated $156K and bringing the position to 67,349 shares worth $15.1M. The position accounts for 0.8% of the portfolio, ranked #65.

Distillate Capital Partners first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $16.1M in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Distillate Capital Partners held 67,349 shares of ResMed worth $15.1M as of Q1 2026.
  • Distillate Capital Partners bought 624 ResMed shares in Q1 2026, an estimated $156K.
  • ResMed made up 0.8% of Distillate Capital Partners's portfolio in Q1 2026, its #65 holding.
  • Distillate Capital Partners first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • Distillate Capital Partners's ResMed position peaked at $16.1M in Q4 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Distillate Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.